newsfilter
← Latest News
GlobeNewswire·

CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes

BOSTON, March 17, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ:CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, toda